NCT01323660 - An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B | Biotech Hunter

Enrollment

307

Participants

Timeline

Start Date

March 16, 2011

Primary Completion Date

July 1, 2012

Study Completion Date

July 16, 2012

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK573719/GW642444 125/25

125mcg/ 25mcg QID (Once daily , inhaled)

DRUG

GSK573719/GW642444 62.5/25

62.5mcg/25mcg QID

DRUG

GSK573719 125

125mcg QID

DRUG

GSK573719 62.5

62.5mcg QID

DRUG

GW642444 25

25mcg QID

DEVICE

placebo

Comparator QID

Trial Locations (53)

2400

GSK Investigational Site, København NV

2650

GSK Investigational Site, Hvidovre

5000

GSK Investigational Site, Odense C

6529

GSK Investigational Site, George

7500

GSK Investigational Site, Panorama

7700

GSK Investigational Site, Mowbray

7764

GSK Investigational Site, Gatesville

8000

GSK Investigational Site, Aarhus C

9301

GSK Investigational Site, Bloemfontein

14059

GSK Investigational Site, Prague

14800

GSK Investigational Site, Prague

23225

GSK Investigational Site, Richmond

28207

GSK Investigational Site, Charlotte

29640

GSK Investigational Site, Easley

30046

GSK Investigational Site, Lawrenceville

30106

GSK Investigational Site, Austell

33511

GSK Investigational Site, Brandon

35501

GSK Investigational Site, Jasper

48152

GSK Investigational Site, Livonia

63141

GSK Investigational Site, St Louis

63301

GSK Investigational Site, Saint Charles

66606

GSK Investigational Site, Topeka

70868

GSK Investigational Site, Ostrava - Poruba

77380

GSK Investigational Site, The Woodlands

78758

GSK Investigational Site, Austin

80528

GSK Investigational Site, Fort Collins

83003

GSK Investigational Site, Donetsk

87108

GSK Investigational Site, Albuquerque

90505

GSK Investigational Site, Torrance

06105

GSK Investigational Site, Hartford

29406-7108

GSK Investigational Site, Charleston

L8N 3Z5

GSK Investigational Site, Hamilton

M3H 5S4

GSK Investigational Site, Toronto

M5T 3A9

GSK Investigational Site, Toronto

H2W 1T8

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Québec

500 05

GSK Investigational Site, Hradec Králové

360 09

GSK Investigational Site, Karlovy Vary

Unknown

GSK Investigational Site, Prague

415 10

GSK Investigational Site, Teplice

0181

GSK Investigational Site, Groenkloof

03680

GSK Investigational Site, Kiev

03038

GSK Investigational Site, Kyiv

03115

GSK Investigational Site, Kyiv

LE3 9QP

GSK Investigational Site, Leicester

HA6 2RN

GSK Investigational Site, Northwood

B9 5SS

GSK Investigational Site, Birmingham

BD9 6RJ

GSK Investigational Site, Bradford

HU16 5JQ

GSK Investigational Site, Cottingham, East Yorkshire

DN2 5LT

GSK Investigational Site, Doncaster

G11 6NT

GSK Investigational Site, Glasgow

TA1 5DA

GSK Investigational Site, Somerset

WV10 00B

GSK Investigational Site, Wolverhampton